This page contains a Flash digital edition of a book.
Private Healthcare Spire Healthcare |


including orthopaedics, gynaecology, cardiology, neurology, oncology and general surgery and also diagnostic services including imaging and pathology. The Group also offers outpatient services, such as consulting, minor procedures, treatments, health checks and physiotherapy. In 2014 Spire delivered tailored, personalised


care to more than 260,000 in-patients and day- case patients, and is the leading private provider by volume of knee and hip operations in the United Kingdom. As well as leading medical care, Spire places


a high emphasis on looking after people rather than just treating patients. In 2014, 92% of patients rated the care and attention from nurses as either excellent or very good and 98% of consultants would recommend Spire to a friend or family member. More than £654 million has been invested in Spire


hospitals since 2007. This huge investment has created facilities accredited as specialist centres for a range of medical and surgical specialties. Included within this investment is a commitment to develop a UK wide range of specialist cancer services. Spire currently has four radiotherapy centres in


partnership with Cancer Partners UK but its £13m Bristol radiotherapy centre (The Specialist Care Centre) is the first of a planned nationwide network of specialist centres. The centres will offer diagnostics, chemotherapy, radiotherapy, cancer surgery and ongoing care for cancer patients and survivors. The Specialist Care Centre in Bristol hosts an all-


Main image:


Bristol (Aztec West) and


reception (below)


important state-of-the-art linear accelerator (LinAc), enabling Intensity Modulated and Image Guided Radiotherapy treatment. For Dr Amit Bahl, Consultant Clinical Oncologist, the Centre shows the way forward in cancer treatments. “The Spire Specialist Centre in Bristol offers state of the art radiotherapy with precision planning and


SPIRE HEALTHCARE FACT FILE


l Out-patients: 260,000 in-patient and day-case appointments were carried out at Spire in 2014 l Infection control: 0.00 rate of MRSA per 10,000 bed days l Satisfaction: 92% of patients rated the care and


attention from nurses as ‘excellent’ or ‘very good’ l Recommendation: 98% of consultants would


recommend Spire to a friend or family member l Investment: £654m+ capital investment has been made into Spire hospitals since 2007 l Spire Healthcare - voted Private Hospital Group of the year 2014 by Health Investor Magazine


delivery of treatment,” he says. “The feedback from patients treated has been overwhelmingly positive and they have all praised the individualised care and support provided through their cancer treatment pathway,” Bristol is one of few sites outside London offering


this service and allows Spire to deliver the entire cancer treatment pathway. Its success shows that private provision can play a key role in the future of cancer treatment. “Flexibility around treatment times with the option


of having radiotherapy treatment during the evenings or over the weekends has enabled patients to continue their normal working lives whilst undergoing their treatment schedule,” says Dr Bahl. In December 2014 Spire announced plans for


a second cancer centre next to Baddow Hospital in Chelmsford, Essex. This centre will comprise a radiotherapy facility, housing two state-of-the- art linear accelerators, a wide-bore CT scanner, consultant rooms and an eight bay chemotherapy suite. This centre supports Spire’s commitment to providing quality cancer care across the country. As they look to strengthen their position as a


leading UK private hospital group, Spire has also had approved planning applications for two new hospitals in Manchester and Nottingham to extend the range of services offered and grow its network of consultants, hospitals and clinics. “Spire continues to invest heavily to provide our


referring clinicians with the most up to date facilities and equipment, while all the time widening the range of specialities and conditions we treat”, says Neil McCullough, Business Development Director. “Since 2007 we have increased our number of


operating theatres from 103 to 122, with many more either under construction or planned. We are now looking forward to the next exciting phase of our growth story, which begins with two new state-of-the- art hospitals and a network of specialist care centres across the UK.”


Further information For further information about Spire Healthcare visit www.spirehealthcare.com or call 0808 223 0039


global-opportunity.co.uk Issue 01 | Global Opportunity Healthcare 2015 89


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130  |  Page 131  |  Page 132  |  Page 133  |  Page 134  |  Page 135  |  Page 136  |  Page 137  |  Page 138  |  Page 139  |  Page 140  |  Page 141  |  Page 142  |  Page 143  |  Page 144  |  Page 145  |  Page 146  |  Page 147  |  Page 148  |  Page 149  |  Page 150  |  Page 151  |  Page 152  |  Page 153  |  Page 154  |  Page 155  |  Page 156  |  Page 157  |  Page 158  |  Page 159  |  Page 160  |  Page 161  |  Page 162  |  Page 163  |  Page 164  |  Page 165  |  Page 166  |  Page 167  |  Page 168  |  Page 169  |  Page 170  |  Page 171  |  Page 172  |  Page 173  |  Page 174  |  Page 175  |  Page 176  |  Page 177  |  Page 178  |  Page 179  |  Page 180  |  Page 181  |  Page 182  |  Page 183  |  Page 184  |  Page 185  |  Page 186  |  Page 187  |  Page 188  |  Page 189  |  Page 190  |  Page 191  |  Page 192  |  Page 193  |  Page 194  |  Page 195  |  Page 196  |  Page 197  |  Page 198  |  Page 199  |  Page 200  |  Page 201  |  Page 202  |  Page 203  |  Page 204